Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H-Receptor Antagonist, in Patients with Seasonal Allergic Rhinitis: Assessment during the Spring and Fall Allergy Seasons

Author： Meltzer E.O.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.21, Iss.1, 2001-01, pp. : 25-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Tolerability Comparison of Ebastine 10 and 20mg with Loratadine 10mg: A Double-Blind, Randomised Study in Patients with Perennial Allergic Rhinitis

By Davies R.J.  

Clinical Drug Investigation, Vol. 16, Iss. 6, 1998-12 ,pp. : 413-420

Adis International

Access to resources Recommend Favorite

Safety and Efficacy of Desloratadine in Subjects with Seasonal Allergic Rhinitis or Chronic Urticaria: Results of Four Postmarketing Surveillance Studies

By Bachert Claus  

Clinical Drug Investigation, Vol. 30, Iss. 2, 2010-02 ,pp. : 109-122

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Fluticasone Furoate Nasal Spray Once Daily in Paediatric Patients Aged 6-11 Years with Allergic Rhinitis: Subanalysis of Three Randomized, Double-Blind, Placebo-Controlled, Multicentre Studies

By Meltzer Eli O.  

Clinical Drug Investigation, Vol. 29, Iss. 2, 2009-01 ,pp. : 79-86

Adis International

Access to resources Recommend Favorite

Efficacy and Safety Assessment of a Novel Once-Daily Tablet Formulation of Tramadol: A Randomised, Controlled Study versus Twice-Daily Tramadol in Patients with Osteoarthritis of the Knee

By Gérald Mongin  

Clinical Drug Investigation, Vol. 24, Iss. 9, 2004-01 ,pp. : 545-558

Adis International

Access to resources Recommend Favorite

Predicting and Establishing the Clinical Efficacy of a Histamine H1-Receptor Antagonist: Desloratadine, the Model Paradigm

By Glenis Scadding  

Clinical Drug Investigation, Vol. 25, Iss. 3, 2005-01 ,pp. : 153-164

Adis International

Access to resources Recommend Favorite